Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 15

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Subjective cancer-related cognitive impairments and salience network connectivity in breast cancer survivors

Henneghan, Ashley M., Kesler, Shelli R.·2023·Journal of Cancer Survivorship
DOI 10.1007/s11764-022-01307-8
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11764-022-01307-8

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 48

  1. Lange M, Joly F, Vardy J, Ahles T, Dubois M, Tron L, Winocur G, De Ruiter MB, Castel H. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol. 2019;30(12):1925–40. · DOI · Paper page
  2. Selamat MH, Loh SY, Mackenzie L, Vardy J. Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications. PLoS One. 2014;9(9):e108002. · DOI
  3. Porro B, Durand MJ, Petit A, Bertin M, Roquelaure Y. Return to work of breast cancer survivors: toward an integrative and transactional conceptual model. J Cancer Surviv. 2021;16(3):590–603. · DOI
  4. Mayo SJ, Lustberg M, Dhillon HM, Nakamura ZM, Allen DH, Von ah D, Janelsins MC, Chan A, Olson K, Tan CJ, Toh YL, Oh J, Grech L, Cheung YT, Subbiah IM, Petranovic D, D’Olimpio J, Gobbo M, Koeppen S, Loprinzi CL, Pang L, Shinde S, Ntukidem O, Peters KB. Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group. Support Care Cancer. 2021;29(6):2821–40. · DOI
  5. Bray VJ, Dhillon HM, Vardy JL. Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. J Cancer Surviv. 2018;12(4):537–59. · DOI
  6. Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev. 2012;38(7):926–34. · DOI
  7. Wefel JS, Kesler SR, Noll KR, Schagen SB. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin. 2015;65(2):123–38. · DOI
  8. Kaiser J, Bledowski C, Dietrich J. Neural correlates of chemotherapy-related cognitive impairment. Cortex. 2014;54:33–50. · DOI
  9. Simo M, Rifa-Ros X, Rodriguez-Fornells A, Bruna J. Chemobrain: a systematic review of structural and functional neuroimaging studies. Neurosci Biobehav Rev. 2013;37(8):1311–21. · DOI
  10. Kesler S, Janelsins M, Koovakkattu D, Palesh O, Mustian K, Morrow G, Dhabhar FS. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun. 2013;30(Suppl):S109–16. · DOI
  11. Kesler SR. Prevalence of cerebral small-vessel disease in long-term breast cancer survivors exposed to both adjuvant radiotherapy and chemotherapy. Breast Diseases: A Year Book Quarterly. 2015;26(4):353.
  12. Correa DD, Ahles TA. Neurocognitive changes in cancer survivors. Cancer J. 2008;14(6):396–400. · DOI
  13. Wefel JS, Vardy J, Ahles T, Schagen SB. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011;12(7):703–8. · DOI
  14. Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR. An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol. 2011;38(3):431–8. · DOI
  15. Vardy J. Cognitive function in breast cancer survivors. Cancer Treat Res. 2009;151:387–419. · DOI
  16. Wefel JS, Saleeba AK, Buzdar AU, Meyers CA. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2010;116(14):3348–56. · DOI
  17. Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J. A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer. 2005;104(10):2222–33. · DOI
  18. McDonald BC, Conroy SK, Smith DJ, West JD, Saykin AJ. Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain Behav Immun. 2013;30(Suppl):S117–25. · DOI
  19. Kesler SR, Kent JS, O’Hara R. Prefrontal cortex and executive function impairments in primary breast cancer. Arch Neurol. 2011;68(11):1447–53. · DOI
  20. Askren MK, Jung M, Berman MG, Zhang M, Therrien B, Peltier S, Ossher L, Hayes DF, Reuter-Lorenz PA, Cimprich B. Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation. Breast Cancer Res Treat. 2014;147(2):445–55. · DOI
  21. Apple AC, Schroeder MP, Ryals AJ, Wagner LI, Cella D, Shih PA, Reilly J, Penedo FJ, Voss JL, Wang L. Hippocampal functional connectivity is related to self-reported cognitive concerns in breast cancer patients undergoing adjuvant therapy. NeuroImage Clin. 2018;20:110–8. · DOI
  22. S.R. Kesler, T. Tang, A.M. Henneghan, M. Wright, M.W. Gaber, O. Palesh, Cross-sectional characterization of local brain network connectivity pre and post breast cancer treatment and distinct association with subjective cognitive and psychological function, Frontiers in neurology 12(1969) (2021). · DOI
  23. Kesler SR, Wefel JS, Hosseini SM, Cheung M, Watson CL, Hoeft F. Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls. Proc Natl Acad Sci USA. 2013;110(28):11600–5. · DOI
  24. Dumas JA, Makarewicz J, Schaubhut GJ, Devins R, Albert K, Dittus K, Newhouse PA. Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study. Brain Imaging Behav. 2013;7(4):524–32. · DOI
  25. Zeng Y, Cheng ASK, Song T, Sheng X, Zhang Y, Liu X, Chan CCH. Subjective cognitive impairment and brain structural networks in Chinese gynaecological cancer survivors compared with age-matched controls: a cross-sectional study. BMC Cancer. 2017;17(1):796. · DOI
  26. Chand GB, Wu J, Hajjar I, Qiu D. Interactions of the salience network and its subsystems with the default-mode and the central-executive networks in normal aging and mild cognitive impairment. Brain Connectivity. 2017;7(7):401–12. · DOI
  27. Seeley WW. The salience network: a neural system for perceiving and responding to homeostatic demands. J Neurosci. 2019;39(50):9878–82. · DOI · Paper page
  28. Chong JSX, Ng GJP, Lee SC, Zhou J. Salience network connectivity in the insula is associated with individual differences in interoceptive accuracy. Brain Struct Funct. 2017;222(4):1635–44. · DOI · Paper page
  29. Roth RM, Lance CE, Isquith PK, Fischer AS, Giancola PR. Confirmatory factor analysis of the behavior rating inventory of executive function-adult version in healthy adults and application to attention-deficit/hyperactivity disorder. Arch Clin Neuropsychol. 2013;28(5):425–34. · DOI · Paper page
  30. Troyer AK, Rich JB. Psychometric Properties of a New Metamemory Questionnaire for Older Adults. J Gerontol B Psychol Sci Soc Sci. 2002;57(1):P19–27. · DOI
  31. AAghakhani EK Chan Test Reviews: Bracken BA, Howell K 2004. Clinical Assessment of Depression Odessa, FL: Psychological Assessment Resources. J Psychoeduc Assess. 2007;25(4):416–22. · DOI
  32. Glover GH, Lai S. Self-navigated spiral fMRI: interleaved versus single-shot. Magn Reson Med. 1998;39(3):361–8. · DOI
  33. Ashburner J. SPM: a history. Neuroimage. 2012;62(2):791–800. · DOI
  34. Whitfield-Gabrieli S, Nieto-Castanon A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connectivity. 2012;2(3):125–41. · DOI · Paper page
  35. Behzadi Y, Restom K, Liau J, Liu TT. A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. Neuroimage. 2007;37(1):90–101. · DOI · Paper page
  36. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15(1):273–89. · DOI · Paper page
  37. Van der Gucht K, Ahmadoun S, Melis M, de Cloe E, Sleurs C, Radwan A, Blommaert J, Takano K, Vandenbulcke M, Wildiers H, Neven P, Kuppens P, Raes F, Smeets A, Sunaert S, Deprez S. Effects of a mindfulness-based intervention on cancer-related cognitive impairment: results of a randomized controlled functional magnetic resonance imaging pilot study. Cancer. 2020;126(18):4246–55. · DOI
  38. R.M. Roth, P.K. Isquith, G. Gioia, Behavioral rating inventory of executive function - adult version, Psychological Assessment Resources, Lutz, FL, 2005. · DOI · Paper page
  39. Bernstein LJ, Edelstein K, Sharma A, Alain C. Chemo-brain: an activation likelihood estimation meta-analysis of functional magnetic resonance imaging studies. Neurosci Biobehav Rev. 2021;130:314–25. · DOI · Paper page
  40. Gratton C, Sun H, Petersen SE. Control networks and hubs. Psychophysiol. 2018;55(3):e13032. · DOI
  41. Hou J, Song B, Chen ACN, Sun C, Zhou J, Zhu H, Beauchaine TP. Review on neural correlates of emotion regulation and music: implications for emotion dysregulation. Front Psychol. 2017;8:501.
  42. Conley CC, Bishop BT, Andersen BL. Emotions and emotion regulation in breast cancer survivorship. Healthcare (Basel). 2016;4(3):56. · DOI
  43. Arndt J, Das E, Schagen SB, Reid-Arndt SA, Cameron LD, Ahles TA. Broadening the cancer and cognition landscape: the role of self-regulatory challenges. Psychooncol. 2014;23(1):1–8. · DOI
  44. Perrier J, Joue G, Desgranges B, Allouache D, Levy C, Noal S, Dayan J, Eustache F, Joly F, Viard A, Giffard B. Self-referential processes and resting-state connectivity in breast cancer patients before and 1 year after chemotherapy. Eur J Neurosci. 2022;55(2):624–36. · DOI
  45. Kesler SR, Wayfull JS, Hosseini SM, Cheung M, Watson CL, Hoeft F. Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls. Proc Natl Acad Sci USA. 2013;110(28):11600–5. · DOI
  46. Sharma N, Murari G, Vandermorris S, Verhoeff N, Herrmann N, Chen JJ, Mah L. Functional connectivity between the posterior default mode network and parahippocampal gyrus is disrupted in older adults with subjective cognitive decline and correlates with subjective memory ability. J Alzheimer’s Disease : JAD. 2021;82(1):435–45. · DOI
  47. Costa DSJ, Fardell JE. Why are objective and perceived cognitive function weakly correlated in patients with cancer? J Clin Oncol. 2019;37(14):1154–8. · DOI
  48. Janelsins MC, Kesler SR, Ahles TA, Morrow GR. Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry. 2014;26(1):102–13. · DOI · Paper page

Metadata

Authors
Henneghan, A. M., & Kesler, S. R.
Venue
Journal of Cancer Survivorship
Publisher
Springer Science and Business Media LLC
Published
2022-12-05
Volume
17
Issue
4
Pages
967-973
ISSN
  • 1932-2259
  • 1932-2267
DOI
10.1007/s11764-022-01307-8
Cited by
15
References
5
Language
en
Licence
Funders
  • National Institute of Nursing Research (K01NR018970)
  • National Cancer Institute (R01CA226080)
  • NIH Office of the Director (DP2OD004445)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Subjective cancer-related cognitive impairments and salience network connectivity in breast cancer survivors. https://app.cochat.ai/papers/10.1007/s11764-022-01307-8
The paper
Henneghan, A. M., & Kesler, S. R. (2023). Subjective cancer-related cognitive impairments and salience network connectivity in breast cancer survivors. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-022-01307-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.